ClinicalTrials.govpublic full text
An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children
human immunodeficiency virus, open label pharmacokinetic safety and efficacy in hiv-1 infected pediatrics, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 912283
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.